197 related articles for article (PubMed ID: 33765945)
1. Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.
Gorriz JL; Arroyo D; D'Marco L; Torra R; Tomás P; Puchades MJ; Panizo N; Pantoja J; Montomoli M; Llisterri JL; Pallares-Carratalá V; Valdivielso JM
BMC Nephrol; 2021 Mar; 22(1):110. PubMed ID: 33765945
[TBL] [Abstract][Full Text] [Related]
2. α-lipoic acid in patients with autosomal dominant polycystic kidney disease.
Lai S; Petramala L; Muscaritoli M; Cianci R; Mazzaferro S; Mitterhofer AP; Pasquali M; D'Ambrosio V; Carta M; Ansuini M; Ramaccini C; Galani A; Amabile MI; Molfino A; Letizia C
Nutrition; 2020 Mar; 71():110594. PubMed ID: 31790890
[TBL] [Abstract][Full Text] [Related]
3. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
[TBL] [Abstract][Full Text] [Related]
4. Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease.
Lai S; Mastroluca D; Matino S; Panebianco V; Vitarelli A; Capotosto L; Turinese I; Marinelli P; Rossetti M; Galani A; Baiocchi P; D'Angelo AR; Palange P
Kidney Blood Press Res; 2017; 42(6):1290-1302. PubMed ID: 29262409
[TBL] [Abstract][Full Text] [Related]
5. Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
Lai S; Petramala L; Mastroluca D; Petraglia E; Di Gaeta A; Indino E; Panebianco V; Ciccariello M; Shahabadi HH; Galani A; Letizia C; D'Angelo AR
Medicine (Baltimore); 2016 Jul; 95(29):e4175. PubMed ID: 27442639
[TBL] [Abstract][Full Text] [Related]
6. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
Coban M; Inci A; Yılmaz U; Asilturk E
Kidney Blood Press Res; 2018; 43(4):1160-1173. PubMed ID: 30064143
[TBL] [Abstract][Full Text] [Related]
7. Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
Lai S; Mittherhofer AP; Cianci R; Riviello L; Vocaturi M; Mastroluca D; Ciccariello M; Von Heland M; Ricciuti GP; Salciccia S; Mazzaferro S
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2734-2743. PubMed ID: 31002123
[TBL] [Abstract][Full Text] [Related]
8. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study.
Arroyo D; Betriu A; Martinez-Alonso M; Vidal T; Valdivielso JM; Fernández E;
BMC Nephrol; 2014 Oct; 15():168. PubMed ID: 25326683
[TBL] [Abstract][Full Text] [Related]
9. Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective.
Abou Heidar N; Chehab O; Morsi RZ; Elias J; El Mouhayyar C; Kanj A; Ajam M; Haykal A; Pahuja M; Dakik H; Levine D; Imran N; Abidov A
Clin Exp Nephrol; 2022 Jul; 26(7):659-668. PubMed ID: 35212882
[TBL] [Abstract][Full Text] [Related]
10. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
[TBL] [Abstract][Full Text] [Related]
11. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
[TBL] [Abstract][Full Text] [Related]
12. Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.
Sági B; Késői I; Késői B; Vas T; Csiky B; Kovács T; Nagy J
Physiol Int; 2018 Jun; 105(2):145-156. PubMed ID: 29975128
[TBL] [Abstract][Full Text] [Related]
13. Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease.
Barrios C; Pascual J; Otero S; Soler MJ; Rodríguez E; Collado S; Faura A; Mojal S; Navarro-González JF; Betriu A; Fernandez E; Valdivielso JM;
Atherosclerosis; 2015 Sep; 242(1):37-44. PubMed ID: 26177272
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
[TBL] [Abstract][Full Text] [Related]
15. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
[TBL] [Abstract][Full Text] [Related]
16. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
17. Subclinic arterial and left ventricular systolic impairment in autosomal dominant polycystic kidney disease with preserved renal functions.
Akpinar TS; Kucukdagli P; Ozer PK; Karaayvaz EB; Ince B; Bakkaloglu OK; Sarihan I; Medetalibeyoglu A; Altinkaynak M; Uzun DD; Bozbora E; Kose M; Ecder T; Yazici H
Int J Cardiovasc Imaging; 2022 Feb; 38(2):271-278. PubMed ID: 34436702
[TBL] [Abstract][Full Text] [Related]
18. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease.
Kocaman O; Oflaz H; Yekeler E; Dursun M; Erdogan D; Demirel S; Alisir S; Turgut F; Mercanoglu F; Ecder T
Am J Kidney Dis; 2004 May; 43(5):854-60. PubMed ID: 15112176
[TBL] [Abstract][Full Text] [Related]
20. Mortality risk in patients with autosomal dominant polycystic kidney disease.
Mladsi D; Zhou X; Mader G; Sanon M; Wang J; Barnett C; Willey C; Seliger S
BMC Nephrol; 2024 Feb; 25(1):56. PubMed ID: 38365638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
